Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaKERN is a Portuguese pharmaceutical company and a subsidiary of the Spanish Indukern Group. Founded in 2005, the company focuses on the development, marketing, and distribution of generic medicines, over-the-counter (OTC) products, and consumer healthcare solutions. It operates primarily in the Portuguese market, offering a wide range of therapeutic solutions across areas such as the central nervous system, cardiovascular health, and pain management. PharmaKERN leverages the manufacturing and R&D capabilities of its parent group, Kern Pharma, to provide high-quality, affordable healthcare products. The company is committed to improving patient access to essential medicines through a robust portfolio of prescription and non-prescription treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaKERN.